| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918912 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
This large, single-institution experience of definitive chemoradiation for ASCC using CRT vs. IMRT demonstrates that outcomes are not compromised by more conformal radiotherapy. In the absence of prospective, multi-institutional, randomized trials of IMRT in ASCC, these retrospective data, using methods to minimize bias, can help to establish the role of IMRT in the definitive therapy of ASCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tina Dasgupta, Diana Rothenstein, Joanne F. Chou, Zhigang Zhang, Jean L. Wright, Leonard B. Saltz, Larissa K. Temple, Philip B. Paty, Martin R. Weiser, Jose G. Guillem, Garrett M. Nash, Karyn A. Goodman,